Stealth BioTherapeutics

FDA Adcomm
Biotech

After agony, FDA adcomm favors Stealth's ultra-rare disease drug

The FDA advisory committee voted 10-6 supporting Stealth Biotherapeutics’ elamipretide for treating Barth syndrome.
Gabrielle Masson Oct 10, 2024 6:20pm
stealth cloak mask hide sneaky shady

Stealth handed cloaking device as go-private merger advances

Aug 1, 2022 12:53pm
stealth fighter jets sneak hide

Stealth could get sneakier with Morningside's go-private pitch

Jun 27, 2022 11:00am
boardroom

Stealth granted FDA meeting to revive elamipretide filing

Jun 14, 2022 10:10am
fail

Stealth stumbles again as AMD joins list of clinical trial flops

May 2, 2022 9:05am
stop sign

Stealth rare disease drug denied by FDA in I told you so moment

Oct 20, 2021 9:30am